Fetal Death in UteroMFUNCT06202508
Fetal Death in Utero in the Internship Experience of Midwifery Students : an Unavoidable Experience?
An observational study of Fetal Death in Utero, run by University Hospital, Strasbourg, France at 1 site in France.
Trial summary
Fetal death in utero and the psychological and professional impact it could have on the midwifery student in training. Fetal death in utero corresponds to the spontaneous cessation of cardiac activity, from 14 weeks of amenorrhea. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Fetal Death in Utero
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 18 Jun 2021to 18 Jun 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Midwifery student of the Strasbourg school of medicine having experienced the discovery of a fetal death in utero in a birth room internship
Who may be able to join
- Age ≥18 years
- Midwifery student of the Strasbourg school of medicine of 3rd year or more
- having experienced the discovery of a fetal death in utero in a birth room internship
- having participated in the follow-up of an in utero fetal death in the birth room
- Agreed to participate in the interview and did not express opposition to the reuse of their data for the purpose of this research
Who cannot join
- Subject who expressed opposition to participating in the study
Trial locations and contacts
1 site in 1 country.
France1 site
Service de Gynécologie Obstétrique - CHU de Strasbourg - France
Strasbourg, 67091
About this study
Fetal death in utero and the psychological and professional impact it could have on the midwifery student in training. Fetal death in utero corresponds to the spontaneous cessation of cardiac activity, from 14 weeks of amenorrhea.
For a large proportion of midwifery students, fetal death in utero is a situation encountered in the field. Despite the theoretical courses, a student does not expect to encounter this type of situation during the internship: it is delicate for both the supervising caregivers and the student. The purpose of this study is to demonstrate the impact that this situation could have on the midwifery student, both psychologically and in terms of their professional project.
Read the detailed description
The aim of the research is to highlight the psychological and professional impact of in utero fetal death among midwifery students in Strasbourg.
- Conditions
- Fetal Death in Utero
- Keywords
- Fetal death in utero
- Medical subject headings
- Stillbirth
What is being measured
The primary outcome is the main question the study is designed to answer.
To highlight the psychological and professional impact of in utero fetal death on Strasbourg midwifery students.
Analysis of midwifery students' experiences during their internship in Strasbourg through semi-directive interviews
Measured: Approximately 10 months after a midwifery student was in charge of a case of fetal death in utero
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Jan 2024
- Study start18 Jun 2021
- Primary completion18 Apr 2022
- Study completion18 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fetal Death in UteroStudies of the same condition, open and under way.
- More trials run by University Hospital, Strasbourg, FranceThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Other
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Strasbourg, France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06202508
- Sponsor's protocol ID
- 8335
- Acronym
- MFU
- Status last verified
- Jan 2024
- First submitted
- 14 Dec 2022
- Last updated
- 11 Jan 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fetal Death in Utero in the Internship Experience of Midwifery Students : an Unavoidable Experience?
- ClinicalTrials.gov ID
- NCT06202508
- Acronym / sponsor ID
- MFU / 8335
- Conditions
- Fetal Death in Utero
- Keywords
- Fetal death in utero
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- University Hospital, Strasbourg, FranceUniversity, hospital or other
- Study start
- 18 Jun 2021 (actual)
- Primary completion
- 18 Apr 2022 (actual)
- Study completion
- 18 Jun 2022 (actual)
- First posted
- 11 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Fetal death in utero and the psychological and professional impact it could have on the midwifery student in training. Fetal death in utero corresponds to the spontaneous cessation of cardiac activity, from 14 weeks of amenorrhea.
For a large proportion of midwifery students, fetal death in utero is a situation encountered in the field. Despite the theoretical courses, a student does not expect to encounter this type of situation during the internship: it is delicate for both the supervising caregivers and the student. The purpose of this study is to demonstrate the impact that this situation could have on the midwifery student, both psychologically and in terms of their professional project.
Detailed description
The aim of the research is to highlight the psychological and professional impact of in utero fetal death among midwifery students in Strasbourg.
Study design
- Observational model
- Case only
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Midwifery student of the Strasbourg school of medicine having experienced the discovery of a fetal death in utero in a birth room internship
Key inclusion criteria (5 listed)
- Age ≥18 years
- Midwifery student of the Strasbourg school of medicine of 3rd year or more
- having experienced the discovery of a fetal death in utero in a birth room internship
- having participated in the follow-up of an in utero fetal death in the birth room
- Agreed to participate in the interview and did not express opposition to the reuse of their data for the purpose of this research
Key exclusion criteria (1 listed)
- Subject who expressed opposition to participating in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To highlight the psychological and professional impact of in utero fetal death on Strasbourg midwifery students.
Time frame: Approximately 10 months after a midwifery student was in charge of a case of fetal death in utero
Analysis of midwifery students' experiences during their internship in Strasbourg through semi-directive interviews
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Jan 2024.
Related trials for Fetal Death in Utero
Recruiting
Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths
Repeated Spontaneous Miscarriages, Fetal Deaths in Utero
Recruiting
Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis
Chronic Histiocytic Intervillositis, Intrauterine Growth Retardation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fetal Death in Utero, run by University Hospital, Strasbourg, France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To highlight the psychological and professional impact of in utero fetal death on Strasbourg midwifery students. (time frame: Approximately 10 months after a midwifery student was in charge of a case of fetal death in utero). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2024; AzTrials last refreshed its copy on 8 Nov 2026.